Literature DB >> 7689471

Systemic administration of lithium chloride and tacrine increases nitric oxide synthase activity in the hippocampus of rats.

G Bagetta1, R Massoud, P Rodinò, G Federici, G Nisticò.   

Abstract

We planned to ascertain whether the administration of the anticholinesterase, tacrine (5 mg/kg i.p.), to rats pretreated 24 h before with lithium chloride (LiCl; 12 mEq/kg i.p.) produced any change in nitric oxide (NO) synthase activity in the hippocampus. A significant increase in hippocampal Ca(2+)-calmodulin-dependent NO synthase activity occurred 15 min after tacrine injection and was blocked by atropine (5 mg/kg i.p. given 15 min before tacrine) and by N omega-nitro-L-arginine methyl ester (300 micrograms given into one lateral cerebral ventricle 10 min before tacrine), a NO synthase inhibitor. A consistent cyclic guanosine 3',5'-monophosphate (cGMP) accumulation was also seen. In conclusion, the present results show that tacrine given to LiCl-pretreated rats produces a significant increase in NO synthase activity in the hippocampus and this may be responsible, at least in part, for seizures and related brain damage elicited by these drugs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689471     DOI: 10.1016/0014-2999(93)90093-w

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  Nitric oxide synthases in mammals.

Authors:  R G Knowles; S Moncada
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

2.  The inhibitory effects of N omega-nitro-L-arginine methyl ester on nitric oxide synthase activity vary among brain regions in vivo but not in vitro.

Authors:  N A Ayers; L Kapás; J M Krueger
Journal:  Neurochem Res       Date:  1997-01       Impact factor: 3.996

Review 3.  Effects of lithium on inflammation.

Authors:  Ahmad Nassar; Abed N Azab
Journal:  ACS Chem Neurosci       Date:  2014-05-06       Impact factor: 4.418

4.  Cocaine kindling in mice. Responses to N-methyl-D,L-aspartate (NMDLA) and L-arginine.

Authors:  Y Itzhak
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

Review 5.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.